Cantai Therapeutics, Inc.

CIK 1991732 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Cantai Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jan 21, 2026D0001991732-26-000001
Jul 15, 2025D0001991732-25-000002
Nov 20, 2023D/A0001991732-23-000002
Nov 20, 2023D0001991732-23-000001